“ovarian-cancer” Archives

in
Entry Author Date Location
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets 07/18/19 San Francisco
Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D 05/23/19 San Francisco
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer 02/26/19 New York
TCR²’s IPO Raises $75M to Bring Cancer Cell Therapy to Solid Tumors 02/14/19 Boston
Harpoon’s IPO Spears $76M as Prostate Cancer Drug Continues Testing 02/07/19 San Francisco
OncoMed’s Saga Ends in Reverse Merger with UK-Based Mereo BioPharma 12/05/18 San Francisco
FDA Puts Mersana Cancer Study on Partial Hold After Patient Death 07/19/18 Boston
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On 06/29/18 National
Aravive Seeks Nasdaq Perch Via Reverse Merger With Biotech Versartis 06/04/18 Texas
Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists 08/28/17 Boston
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Houston Biotech Oncolix Announces Reverse Merger, Goes Public 08/07/17 Texas
Tesaro Cashes In Again on PARP Blocker With $100M Takeda Deal 07/27/17 Boston
Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters 06/02/17 Indiana
Mersana Plans IPO to Finance Clinical Trials for Breast Cancer Drug 06/02/17 Boston
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug 12/19/16 Boulder/Denver
Safety Issue Triggers Partial FDA Hold for Aduro Bio 10/24/16 San Francisco
Guardant Health Maps Cautious Plans For Blood-Based Cancer Screening 06/03/16 San Francisco
Tour of Texas: Cancer Moonshot, Lumos, Robyn Metcalfe, & Esperance 04/07/16 Texas
Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push 03/30/16 Texas
Big Deals in Texas (ZS Pharma, HomeAway, Gravitant) & Other News 11/09/15 Texas
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial 07/10/15 Seattle
Array and Novartis End Development Deal for Cancer Drug Binimetinib 12/04/14 Boulder/Denver
Page 1 of 2 next page »